To the best of our knowledge, there is no uniform protocol for the management of hypothyroidism-related cardiac tamponade in current guidelines; however, thyroid hormone replacement therapy serves as the cornerstone of treatment and is invariably given to all patients. The gene discussed is TG; the disease is hypothyroidism.